VANCOMYCIN KABI POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 500 MG
Product details
Registration number: SIN15070P
Classification: Prescription Only
Active ingredients: Vancomycin hydrochloride 512mg eqv Vancomycin
Strength: 500mg/vial
Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route: INTRAVENOUS
Registrant: FRESENIUS KABI (SINGAPORE) PTE LTD
ATC code: J01XA01
HSA approval date: 22 August 2016
Manufacturer(s): Xellia Pharmaceuticals ApS
Manufacturing country/countries: DENMARK
What are the HSA registration number and classification for VANCOMYCIN KABI POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 500 MG?
According to the HSA dataset updated 7 August 2026:
Registration number: SIN15070P
Classification: Prescription Only
What active ingredients and strength are recorded for VANCOMYCIN KABI POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 500 MG?
According to the HSA dataset updated 7 August 2026:
Active ingredients: Vancomycin hydrochloride 512mg eqv Vancomycin
Strength: 500mg/vial
Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.
What dosage form and route are recorded for VANCOMYCIN KABI POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 500 MG?
According to the HSA dataset updated 7 August 2026:
Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route: INTRAVENOUS
Who is the recorded registrant for VANCOMYCIN KABI POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 500 MG?
According to the HSA dataset updated 7 August 2026:
Registrant: FRESENIUS KABI (SINGAPORE) PTE LTD
Which manufacturers and countries are listed for VANCOMYCIN KABI POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 500 MG?
According to the HSA dataset updated 7 August 2026:
Manufacturer(s): Xellia Pharmaceuticals ApS
Manufacturing country/countries: DENMARK
Where can I look up VANCOMYCIN KABI POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 500 MG in the HSA register?
Open HSA’s therapeutic product register and search for registration number SIN15070P or the exact product name VANCOMYCIN KABI POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 500 MG. The general register link does not preselect this product.
What are the source dates for this VANCOMYCIN KABI POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 500 MG record?
This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.
The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.
Has this VANCOMYCIN KABI POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 500 MG record had a separate HSA register check?
No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.
Search the HSA register using SIN15070P for the latest record.
Sources and dates
HSA dataset: 2026. Updated: 13 November 2026.
Factual product information only; no dosing, treatment or suitability advice.
Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.
.png)